In a critical meeting Friday, an FDA panel is expected to review data about Pfizer’s booster shots. The Biden administration had hoped to make the booster shots available to everyone starting Monday, but a CDC panel won’t meet until later next week to make its recommendation on the shots.
As the push to ramp up vaccinations continues, the FDA is assessing additional COVID-19 vaccine approvals for kids younger than 12 and booster shots. A source says there’s been some frustration inside the agency about the White House stepping into the FDA’s lane and getting ahead of where the science is by setting booster goals.
Pfizer COVID-19 vaccine granted full FDA authorization as the Biden administration considers approving boosters
Major vaccine news broke Monday as Pfizer’s COVID-19 vaccine was granted full FDA authorization. This comes on the heels of the Biden administration considering approving booster shots, starting mid-September.
The White House says President Joe Biden will lay out his COVID-19 booster shot plan today. Preliminary data suggest the general population might need a booster about eight months after their final dose, and they could be offered by mid to late September, pending authorization from the FDA.
Consumer News: TikTok launches new measures to protect kids, Adidas sells Reebok and more!
The FDA is expected to authorize COVID-19 booster shots for the immunocompromised as early as today. This comes as the nation desperately tries to get the Delta variant under control, with every single state reporting high or substantial community transmission of COVID-19.
NIH Director Dr. Francis Collins says Pfizer may be getting ahead of itself in applying for emergency use authorization for a booster dose of its COVID-19 vaccine.
The FDA issued a new warning about the Johnson & Johnson vaccine, saying it could be linked to a rare neurological disorder.
More than six million Americans are living with Alzheimer’s, but there is new hope for those in the earliest stages of the disease. We’re learning more about the new treatment approved by the FDA.
Vaccine advisers from the Food and Drug Administration met this week to discuss the risks and benefits of COVID-19 shots for kids.